Home » Newsletters » BioWorld Science

BioWorld Science

July 9, 2004

View Archived Issues

Nycomed terminates Oxygent license agreement

FDA approves new dosing options for Prevacid SoluTab

Chiron acquires Sagres Discovery

trans-ISA-247 completes single ascending dose study

End-of-phase II meeting held for HspE7

Icatibant awarded orphan drug status for edema in severe burn patients

U.S. phase I trial of Exherin cleared to begin

New oxymorphone ER trial protocol agreed under SPA

GOG submits IND for Xyotax study in ovarian cancer

DOV reaches agreement with FDA on clinical trial program for DOV diltiazem

Abbott and Celera form cancer therapeutics collaboration

Acusphere and Nycomed in European partnership for AI-700

MeNZB meningococcal B vaccine approved in New Zealand

Procter & Gamble license Geron's hTERT technology for research

Enrollment open in phase II Xolair peanut allergy study

Phase III study shows benefit of Bonviva/Boniva injection at extended intervals

Nebido completes European mutual recognition procedure

Histamine H3 receptor modulators claimed by Kyowa Hakko

Sponge-derived terpenoids reported by Galileo Laboratories

Tyrosine kinase inhibitors patented by Merck KGaA

ArQule describes lapachone analogues

Aminoalcohol derivatives for the treatment of urinary incontinence

AstraZeneca describes glucokinase activators

First clinical evidence of antitumor effects induced by taurolidine in glioblastoma

Potential of novel anxiolytic LY-544344

Antidepressant and anxiolytic properties of agomelatine

Anxiolytic effects of NK1 and CRF1 receptor antagonists in marmosets

Cellular process in cognition enhancement improved by 5-HT6 receptor antagonists

Antiviral nucleoside derivatives for the treatment of hepatitis C

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...